An ATP-sensitive K(+) conductance in dissociated neurones from adult rat intracardiac ganglia.
1. An ATP-sensitive K(+) (K(ATP)) conductance has been identified using the perforated patch recording configuration in a population (52%) of dissociated neurones from adult rat intracardiac ganglia. The presence of the sulphonylurea receptor in approximately half of the intracardiac neurones was confirmed by labelling with fluorescent glibenclamide-BODIPY. 2. Under current clamp conditions in physiological solutions, levcromakalim (10 microM) evoked a hyperpolarization, which was inhibited by the sulphonylurea drugs glibenclamide and tolbutamide. 3. Under voltage clamp conditions in symmetrical (140 mM) K(+) solutions, bath application of levcromakalim evoked an inward current with a density of 8 pA pF(-1) at -50 mV and a slope conductance of approximately 9 nS, which reversed close to the potassium equilibrium potential (E(K)). Cell dialysis with an ATP-free intracellular solution also evoked an inward current, which was inhibited by tolbutamide. 4. Bath application of either glibenclamide (10 microM) or tolbutamide (100 microM) depolarized adult intracardiac neurones by 3-5 mV, suggesting that a K(ATP) conductance is activated under resting conditions and contributes to the resting membrane potential. 5. Activation of a membrane current by levcromakalim was concentration dependent with an EC(50) of 1.6 microM. Inhibition of the levcromakalim-activated current by glibenclamide was also concentration dependent with an IC(50) of 55 nM. 6. Metabolic inhibition with 2,4-dinitrophenol and iodoacetic acid or superfusion with hypoxic solution (P(O2) approximately 16 mmHg) also activated a membrane current. These currents exhibited similar I-V characteristics to the levcromakalim-induced current and were inhibited by glibenclamide. 7. Activation of K(ATP) channels in mammalian intracardiac neurones may contribute to changes in neural regulation of the mature heart and cardiac function during ischaemia-reperfusion.
Hogg
R C
RC
School of Biomedical Sciences, Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072, Australia.
Adams
D J
DJ
D000255:Adenosine Triphosphate / Q000502:physiology*; D000818:Animals; D001896:Boron Compounds; D015687:Cell Hypoxia / Q000502:physiology; D019806:Cromakalim / Q000494:pharmacology; D004553:Electric Conductivity; D005456:Fluorescent Dyes; D005724:Ganglia / Q000378:metabolism*; D005905:Glyburide / Q000494:pharmacology; D006329:Heart Conduction System / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
C095489:4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; D001896:Boron Compounds; D005456:Fluorescent Dyes; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D019806:Cromakalim; D000255:Adenosine Triphosphate; D005905:Glyburide